financetom
Business
financetom
/
Business
/
Carlyle's profit misses estimates on lower proceeds from asset sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Carlyle's profit misses estimates on lower proceeds from asset sales
Feb 11, 2025 3:29 AM

(Reuters) - Carlyle Group's ( CG ) distributable earnings for the fourth quarter missed market expectations on Tuesday, overshadowing a strong growth in the alternative asset manager's capital market business.

The profit miss was largely due to lower proceeds from asset sales, resulting in a 24.1% slide in earnings at its private equity business.

The asset manager's profit available to shareholders stood at $384 million, or 92 cents per share, 4 cents short of analysts' expectations, according to LSEG estimates.

Its realized performance revenue, mostly driven by asset sales from its private equity arm, fell 4.7% to $245.7 million.

Still, Carlyle achieved the financial goals laid out at the start of the last year. Under CEO Harvey Schwartz, Carlyle has prioritized margin growth and investment performance by rejigging leadership and realigning compensation model.

The asset manager reported record fee-related earnings of $287.4 million, a 13% jump from a year ago, while assets under management rose 4% to $441 billion.

Inflows stood at $14.2 billion, driven by its credit business. Carlyle retained $84 billion of unspent capital and deployed $17.6 billion in investments.

CAPITAL MARKETS SHINE

In a bright spot, Carlyle's transaction and portfolio advisory fees more than doubled to $80.6 million in the fourth quarter, exceeding Street expectations of $55.3 million.

Capital markets has been a major focus area for Carlyle since Schwartz took the mantle in early 2023. For 2024, the business had a record year.

Rival KKR last week reported strong growth in its capital markets business.

Carlyle's corporate private equity funds and real estate funds rose 1%, while global credit funds gained 3%.

In terms of exits, Carlyle in October took portfolio companies StandardAero and Rigaku public in the U.S. and Japan, respectively.

The asset manager had in December agreed to sell Italian component maker Forgital to U.S. alternative investment firm Stonepeak in a deal valued at more than 1.5 billion euros ($1.55 billion).

($1 = 0.9691 euros)

(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Arun Koyyur)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cosmos Health Signs Deal to Distribute Virax Biolabs' Mpox PCR Detection Kits in India
Cosmos Health Signs Deal to Distribute Virax Biolabs' Mpox PCR Detection Kits in India
Oct 3, 2024
10:52 AM EDT, 09/23/2024 (MT Newswires) -- Cosmos Health ( COSM ) said Monday that it signed an exclusive agreement with Virax Biolabs to distribute mpox virus real-time PCR detection kits in India. The deal expands the companies' strategic partnership beyond Europe and follows a recent exclusive agreement for Cosmos Health's ( COSM ) distribution of the detection kits in...
Korn Ferry Insider Sold Shares Worth $3,767,804, According to a Recent SEC Filing
Korn Ferry Insider Sold Shares Worth $3,767,804, According to a Recent SEC Filing
Oct 3, 2024
10:17 AM EDT, 09/23/2024 (MT Newswires) -- Robert P Rozek, EVP, CFO & CCO, around September 19, 2024, sold 50,000 shares in Korn Ferry ( KFY ) for $3,767,804. Following the Form 4 filing with the SEC, Rozek has control over a total of 125,456 shares of the company, with 125,456 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/56679/000095017024108541/xslF345X05/ownership.xml Price: 74.84, Change:...
Sanofi CEO still considering how to split consumer biz, hopes to keep a stake
Sanofi CEO still considering how to split consumer biz, hopes to keep a stake
Oct 3, 2024
NEW YORK (Reuters) - Sanofi Chief Executive Paul Hudson said on Monday that the company has not made a final decision yet on how it plans to split off its Opella consumer healthcare unit, but that it is interested in keeping a stake in the business after the separation is done. I'm encouraged by the level of interest in the...
Qualcomm Takeover Of Intel Is 'Logically Unlikely' In Face Of Regulatory Challenges, Analyst Says
Qualcomm Takeover Of Intel Is 'Logically Unlikely' In Face Of Regulatory Challenges, Analyst Says
Oct 3, 2024
Don’t expect Qualcomm Inc ( QCOM ). to buy Intel Corporation ( INTC ) , Benchmark analyst Cody Acree says. Apollo Global Management ( APO ) intends to make a $5-billion investment in Intel ( INTC ). This development occurred after the Wall Street Journal reported that Qualcomm ( QCOM ) was interested in acquiring Intel ( INTC ) outright...
Copyright 2023-2026 - www.financetom.com All Rights Reserved